🇺🇸 FDA
Pipeline program

Cyproterone acetate

F-LEU-100

Phase 3 small_molecule completed

Quick answer

Cyproterone acetate for Adenocarcinoma, Prostate is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Adenocarcinoma, Prostate
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials